BioCardia, Inc. ( BCDA) - Stock Earnings
BCDA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
BCDA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.0 million USD | — USD |
| 2026Q1 | -2.3 million USD | — USD |
| 2026Q2 | -1.6 million USD | — USD |
| 2026Q4 Est. | — | — |
BCDA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -11.6 million USD | 477000 USD |
| 2024 | -7.9 million USD | 58000 USD |
| 2025 | -8.2 million USD | — USD |
| 2026 Est. | — | — |
BCDA
Price: $1.02
52 week price:
Earnings Per Share: -0.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 50500
Market Capitalization: 15.5 million